The oncogene BCR::ABL1 is a key player in chronic myeloid leukemia (CML), as well as in acute lymphoblastic leukemia (ALL), collectively known as Philadelphia chromosome-positive (Ph+) neoplasms. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.